The 20 Best Renal Cell Carcinoma (RCC) Doctors Near Me in Clairton, PA
Find the Top Renal Cell Carcinoma (RCC) Experts and Specialists
MediFind found 101 doctor with experience in Renal Cell Carcinoma (RCC) near Clairton, PA. Of these, 84 are Experienced, 11 are Advanced, 5 are Distinguished and 1 are Elite.
UPMC Hillman Cancer Center
Dr. Kane has practiced for more than 20 years and is board certified in Medical Oncology. He received his medical degree from Ohio State University School of Medicine. He completed his residency training in Hematology/Oncology at the University of Pittsburgh School of Medicine. Dr. Kane is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Non-Hodgkin Lymphoma, Essential Thrombocythemia, Small Cell Lung Cancer (SCLC), and Familial Colorectal Cancer.
UPMC Hillman Cancer Center
Andrew D. Laman, MD, is a hematologist and oncologist at UPMC Hillman Cancer Center. Dr. Laman specializes in hematology and medical oncology. Dr. Laman is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.
Office
Leonard Appleman is an Oncologist in Pittsburgh, Pennsylvania. Dr. Appleman is rated as an Elite provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, and WT1-Related Wilms Tumor Syndromes.
UPMC Department Of Urology
Dr. Maranchie is a surgical oncologist specializing in urologic cancers of the urinary tract and male genitalia. She completed urology residency at Harvard University in 1999, followed by a fellowship in Urologic Oncology at the National Cancer Institute. Her practice is focused on the care of patients with cancer of the kidney, bladder and testis, employing minimally invasive approaches, nephron-sparing and nerve-sparing surgery and urinary tract reconstruction. She has specialty expertise in familial or inherited cancer syndromes, offering targeted surveillance with organ-preserving surgery when indicated.LGBTQIA+ Affirming: This provider has completed training on how to create a safe, comfortable, and welcoming environment for LGBTQIA+ patients. This provider may or may not offer LGBTQIA+ specific medical or surgical care. Please ask when scheduling. Dr. Maranchie is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Nephrectomy, and Cystectomy.
UPMC Department Of Urology
Quoc-Dien Trinh, MD, MBA, serves as the Chair of the Department of Urology, University of Pittsburgh School of Medicine, and Chair of Urology, UPMC. A globally recognized urological surgeon-scientist, Dr. Trinh has been honored with the 2021 Outstanding Citizenship Award from Brigham and Women’s Hospital and the 2022 American Urological Association Young Urologist of the Year award for New England. He is recognized as a Castle Connolly Top Doctor and a Top Asian American Pacific Islander Doctor. Dr. Trinh is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy.
UPMC Department Of Urology
Ronald L. Hrebinko, MD, is a professor of urology at the University of Pittsburgh School of Medicine. He specializes in all genitourinary cancers with special expertise in continent urinary diversion, nephron-sparing surgery for renal cancer, laparoscopic kidney surgery, nerve-sparing surgery for the prostate, and testis cancer.Dr. Hrebinko is board-certified in urology. He received an undergraduate degree with honors from Dartmouth College in N.H., and a medical degree at the University of Pittsburgh School of Medicine. Dr. Hrebinko completed a residency at UPMC in the Department of Surgery, and a fellowship at Roswell Park Cancer Institute, in Buffalo, N.Y.Dr. Hrebinko is a member of professional organizations, such as the American Urologic Association, Society of Urologic Oncology, and the American Society of Clinical Oncology.Are you already a patient of this provider and have a MyUPMC account? Log in to MyUPMC to schedule. Dr. Hrebinko is rated as a Distinguished provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Renal Cell Carcinoma (RCC), Familial Wilms Tumor 2, Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery.
UPMC Hillman Cancer Center, Independence Health System
John K. Waas, DO, is a medical oncologist at UPMC Hillman Cancer Center who practices at Arnold Palmer Medical Oncology at Norwin. Board-certified in medical oncology, Dr. Waas received his medical degree from Philadelphia College of Osteopathic Medicine in Philadelphia. He completed his residency at Lehigh Valley Hospital Center in Allentown, Pa. Dr. Waas is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Congenital Antithrombin 3 Deficiency, Protein C Deficiency, Protein S Deficiency, and Hereditary Resistance to Anti-Vitamin K.
Rong Chung Lin, MD
Rong-chung Lin is a Urologist in Wilkinsburg, Pennsylvania. Dr. Lin is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Prostatectomy.
Oncology-South Mills Medical Building At Jefferson Hospital
Jason Stepp is an Oncologist in Clairton, Pennsylvania. Dr. Stepp is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Inflammatory Breast Cancer, Childhood Iron Deficiency Anemia, Angiosarcoma, and Paget Disease of the Breast.
Oncology-South Mills Medical Building At Jefferson Hospital
Amjad Jalil is a Hematologist in Clairton, Pennsylvania. Dr. Jalil is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Chronic Myelomonocytic Leukemia (CMML), Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration.
Oncology-South Mills Medical Building At Jefferson Hospital
Brian Thomas is a Hematologist in Clairton, Pennsylvania. Dr. Thomas has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Familial Pancreatic Cancer, Pleuropulmonary Blastoma, Lung Cancer, Bone Marrow Aspiration, and Ureteroscopy.
South Pittsburgh Urology Associates
James Allen is a Urologist in Clairton, Pennsylvania. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery.
South Pittsburgh Urology Associates
Vijay Athani is a Urologist in Clairton, Pennsylvania. Dr. Athani is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Familial Prostate Cancer, Prostate Cancer, Enlarged Prostate (BPH), Ureteroscopy, and Reconstructive Urology Surgery.
UPMC Department Of Urology
Bishoy A. Gayed, MD, is an assistant professor of urology at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Missouri Kansas City. Dr. Gayed completed his residency in urology at UPMC and a fellowship in urologic oncology at the University of Texas Southwestern Medical Center. He specializes in urology, urologic oncology, urologic surgery, and the management of tumors of the kidney, bladder, prostate, ureteral, testicular, penile, and adrenal cancers. Dr. Gayed is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Hydronephrosis, Nephrectomy, and Ureteroscopy.
UPMC Department Of Urology
Stephen Jackman, MD, is a urologic surgeon focused on minimally invasive surgery for kidney and prostate cancer as well as kidney stones. His areas of specialty include surgical techniques involving advanced laparoscopy, robotics, and complex kidney stone disease. Dr. Jackman is Professor and Vice Chair of Urology at the University of Pittsburgh School of Medicine. Dr. Jackman is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Kidney Stones, Boils, Folliculitis, Ureteroscopy, and Endoscopy.
UPMC Hillman Cancer Center
Roby A. Thomas, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Thomas is trained in the management of all cancers and blood disorders with a focus in genitourinary and gastrointestinal malignancies. Dr. Thomas is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Prostate Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Gamma Knife Radiosurgery, and Endoscopy.
UPMC Department Of Urology
Benjamin J. Davies, MD, is a professor of urology at the University of Pittsburgh. He specializes in robotic prostatectomy, robotic cystectomy, and kidney and testicular cancer.Dr. Davies is board-certified in urology. He completed an undergraduate degree at Columbia University in New York and a medical degree at Mount Sinai Medical School in New York. Dr. Davies completed a residency at UPMC, and a fellowship of urologic oncology at University of California, San Francisco.Dr. Davies is a member of professional organizations, such as the American Urologic Association, American Medical Association and the Pittsburgh Urologic Society. He also maintains research interests in prostate cancer epidemiology and surgical outcomes. Dr. Davies is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy.
UPMC Department Of Urology
Tatum V. Tarin, MD, is an Associate Professor of Urology at the University of Pittsburgh School of Medicine. He earned his medical degree from the University of Pittsburgh, and completed residencies in surgery and urology at Stanford University Medical Center. He also completed a fellowship in urological oncology at Memorial Sloan-Kettering Cancer Center in New York, N.Y., where he was a clinical instructor for two years prior to joining UPMC. Dr. Tarin is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Bladder Cancer, Urothelial Cancer, Non-Muscle Invasive Bladder Cancer, Lymphadenectomy, and Nephrectomy.
UPMC Department Of Urology
Robert M. Turner, MD is an assistant professor of urology at the University of Pittsburgh School of Medicine. He received his medical degree from Loyola University in Illinois. Dr. Turner completed a residency in urology and a fellowship in urologic oncology at UPMC. He specializes in urology, urologic oncology, and urological surgery. Dr. Turner is rated as an Advanced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). His top areas of expertise are Retroperitoneal Fibrosis, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, Reconstructive Urology Surgery, and Ureteroscopy.
UPMC Hillman Cancer Center
Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is rated as an Experienced provider by MediFind in the treatment of Renal Cell Carcinoma (RCC). Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, and Angiosarcoma.
Last Updated: 02/22/2026













